ULBP2 and acute myeloid leukemia: Shedding of NKG2D ligands, including MICA, MICB and ULBP2, is inhibited by TIMP-3 in acute myeloid leukemia (AML) cells, and this process enhances their sensitivity to lytic activity of NK [118].